SOLUTION
The continuing proliferation of digital technologies have made these advances integral to our daily lives – we have never been more interconnected – and this presents a huge untapped opportunity to address inclusivity in global health, where innovation is occurring at unprecedented scale.
Digital health is an expansive, multidisciplinary concept at the intersection between health and technology embracing hardware, software, and services. The category has evolved to include interconnection of mobile health (mHealth) apps, electronic medical records (EMR), wearable devices, telemedicine, and tailored personalized care, into what today, may be termed the internet of medical things (IoMT).
These emerging technologies empower consumers to participate in monitoring their own health and wellbeing, toward better-informed decisions, providing new options for prevention, early diagnosis, and chronic condition management. When integrated into care pathways, they have the potential to reduce inefficiencies and cost, improve access and quality, and enable personalized treatment regimens. Data, artificial intelligence, and open, secure platforms are central to the promise of a more consumer-focused, inclusive, and prevention-oriented future.
Of course, the application of technology to health intervention is not new. Nonetheless, with global concerns related to population ageing, child illness and mortality, increasing incidence of epidemics and pandemics, rising costs and affordability, poverty, cultural barriers, and discrimination, all impacting access to healthcare, digital health solutions, and related technologies continue to evolve and grow in importance.
This offers a real opportunity for efficiency, and to improve clinical outcomes. To improve life and lives; an opportunity aligned to the vision of Jameel Health.
Featured Partner
EIRL by LPIXEL offers a revolutionary suite of medical image diagnosis support technology, utilizing deep learning-powered AI to interpret medical images across X-ray, CT, MRI, and colonoscopy modalities with high efficiency and accuracy. The technology significantly enhances the diagnostic capabilities of healthcare professionals by improving the sensitivity and speed of analysis.
EIRL Chest Screening technology excels in detecting suspected lung nodules, infiltrative and interstitial shadowing, and atelectasis. It also automates the measurement of critical metrics such as mediastinal width and cardiothoracic ratio, streamlining the diagnostic process. For neurological assessments, EIRL Brain Aneurysm detects up to four suspected aneurysms from MRA scans, increasing detection sensitivity by nearly 10%. Additionally, EIRL Brain Metry and EIRL Brain Segmentation provide comprehensive evaluations by calculating brain matter volumes and differentiating tissue structures in head CT images.
At the heart of EIRL is LPIXEL’s commitment to optimizing healthcare through AI, enhancing diagnostic accuracy, and easing doctors’ workloads. Jameel Health, in collaboration with LPIXEL, continues to redefine medical technology standards, striving for excellence in healthcare delivery across the Global South.
See All Partners